Search Results

Corindus , A Siemens Healthineers Company and a leading developer of precision vascular robotics, announced today it presented the results of a first-of-its-kind study demonstrating the safety and effectiveness of robotic-assisted neurovascular aneurysm embolization using the CorPath GRX Neurovascular System.

Obvius Robotics, a medical device company developing an innovative technology platform for democratizing vascular access, announced its move into a new development and operations facility.

Corindus announced that it will showcase the CorPath GRX System, the first and only FDA-cleared and CE marked medical device for robotic-assisted coronary interventions, at EuroPCR 2022 through live cases, scientific presentations, and multiple Siemens Healthineers-sponsored symposia.

enVVeno Medical Corporation (NASFAQ:NVNO) (“enVVeno” or the “Company”) today announced that positive interim venous ulcer healing data showing significant clinical improvement from the SAVVE U.S. pivotal trial for the VenoValve will be presented today at the Society for Vascular Surgery 2024 Vascular Annual Meeting in Chicago.

enVVeno Medical Corporation (Nasdaq:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of venous disease, today announced that new interim venous ulcer healing data from the VenoValve U.S. pivotal trial will be presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting (VAM2024) being held June 18-22, 2024 in Chicago, IL.

Scientia Vascular, a leader in neurovascular innovation, is thrilled to announce the FDA clearance of two uniquely engineered catheters: the Plato 17—a DMSO-compatible microcatheter—and the Socrates 38, an aspiration catheter engineered for ischemic stroke.

Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, has announced the online publication of the one-year results of the DETOUR2 Trial in the Journal of Vascular Surgery.

Baxter International Inc. announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis.

Sovato announced the use of the Sovato Platform in the successful completion of a series of remote robotic-assisted surgery (RAS) procedures in a preclinical technology demonstration.

Dr. David F. Chang, 2024 Kelman Innovator Lecturer, Presented the Cataract Surgery Robotics Platform at ASCRS Conference